Research and treatments
Latest news on clinical and scientific research in endometriosis.
Cancer-associated mutations in endometriosis without cancer Cancer-causing gene mutations have been found in lesions of women with deep endometriosis – without being cancerous.
Global multi-site endometriosis collaboration enhanced by WERF EPHect National Institutes of Health (NIH) funds five-year project on “integrative analysis of genomic, epigenomic, and phenotypic data for disease stratification of endometriosis”
Women with endometriosis may be at higher risk of coronary heart disease Early surgical menopause (hysterectomy) as a “treatment” for endometriosis may contribute to increased risk of heart disease in younger women.
Endometriosis and co-morbidities Dr Marina Kvaskoff reviews whether women with endometriosis are a population at risk for major chronic diseases, including cancer, allergies, heart disease, and autoimmune diseases.
Pelvic pain may be common among reproductive-age women NIH study finds that more women experience (but don’t report) pelvic pain than previously believed and the majority of these have endometriosis. Researchers suggest physicians consider asking about pain during routine visits.
Quality of life outcomes in women with endometriosis are highly influenced by recruitment strategies Endometriosis has an impact on quality of life – but does the disease affect all women with endometriosis the same way?
Association of chronic pelvic pain and endometriosis with signs of sensitization and myofascial pain NIH study suggests that a comprehensive nerve, muscle, and skeletal examination to identify pain sensitivity and myofascial trigger points may assist in diagnosing endometriosis.
Landmark collaboration publishes tools to enhance global research into endometriosis World Endometriosis Research Foundation releases standardised tools for the collection of all biological samples and clinical data in endometriosis research.
Visceral syndrome in endometriosis A significant number of women with endometriosis may suffer from a specific symptom correlation which is uncommon in women without the disease.
Bayer and University of Oxford in strategic alliance to develop innovative treatments for endometriosis Five-year partnership between Bayer HealthCare and University of Oxford has a goal of discovering and developing targeted treatments for endometriosis and uterine fibroids.
